A Long Term Safety Study of BCX7353 in Hereditary Angioedema
Public ClinicalTrials.gov record NCT03472040. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Study to Evaluate the Long-term Safety of Daily Oral BCX7353 in Subjects With Type I and II Hereditary Angioedema
Study identification
- NCT ID
- NCT03472040
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- BioCryst Pharmaceuticals
- Industry
- Enrollment
- 387 participants
Conditions and interventions
Conditions
Interventions
- BCX7353 Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 15, 2018
- Primary completion
- Apr 26, 2022
- Completion
- Apr 26, 2022
- Last update posted
- Jun 17, 2023
2018 – 2022
United States locations
- U.S. sites
- 42
- U.S. states
- 29
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Center | Birmingham | Alabama | 35209 | — |
| Study Center | Scottsdale | Arizona | 85251 | — |
| Study Center | Bentonville | Arkansas | 72712 | — |
| Study Center | Little Rock | Arkansas | 72205 | — |
| Study Center | San Diego | California | 92123 | — |
| Study Center | Walnut Creek | California | 94598 | — |
| Study Center | Centennial | Colorado | 80112 | — |
| Study Center | Colorado Springs | Colorado | 80907 | — |
| Study Center | Wheat Ridge | Colorado | 80033 | — |
| Study Center | Waterbury | Connecticut | 06708 | — |
| Study Center | Tampa | Florida | 33613 | — |
| Study Center | Marietta | Georgia | 30060 | — |
| Study Center | Normal | Illinois | 61761 | — |
| Study Center | Evansville | Indiana | 47713 | — |
| Study Center | Indianapolis | Indiana | 46202 | — |
| Study Center | Overland Park | Kansas | 66210 | — |
| Study Center | Louisville | Kentucky | 40215 | — |
| Study Center | Chevy Chase | Maryland | 20815 | — |
| Study Center | Boston | Massachusetts | 02114 | — |
| Study Center | Ann Arbor | Michigan | 48106 | — |
| Study Center | Grand Rapids | Michigan | 49506 | — |
| Study Center | Rochester | Minnesota | 55905 | — |
| Study Center | Madison | Mississippi | 39110 | — |
| Study Center | St Louis | Missouri | 63141 | — |
| Study Center | Lincoln | Nebraska | 68505 | — |
| Study Center | Charlotte | North Carolina | 28277 | — |
| Study Center | Durham | North Carolina | 27705 | — |
| Study Center | Cincinnati | Ohio | 45231 | — |
| Study Center | Columbus | Ohio | 43235 | — |
| Study Center | Clackamas | Oregon | 97015 | — |
| Study Center | Happy Valley | Oregon | 97086 | — |
| Study Center | Hershey | Pennsylvania | 17033 | — |
| Study Center | East Providence | Rhode Island | 02914 | — |
| Study Center | Greer | South Carolina | 29651 | — |
| Study Center | Austin | Texas | 78731 | — |
| Study Center | Dallas | Texas | 75231 | — |
| Study Center | Irving | Texas | 75063 | — |
| Study Center | San Antonio | Texas | 78229 | — |
| Study Center | Murray | Utah | 84107 | — |
| Study Center | Seattle | Washington | 98115 | — |
| Study Center | Spokane | Washington | 99202 | — |
| Study Center | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03472040, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 17, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03472040 live on ClinicalTrials.gov.